These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 31398386)

  • 1. Liver Resection for Nonalcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma.
    Koh YX; Tan HJ; Liew YX; Syn N; Teo JY; Lee SY; Goh BKP; Goh GBB; Chan CY
    J Am Coll Surg; 2019 Nov; 229(5):467-478.e1. PubMed ID: 31398386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of perioperative and long-term outcomes of patients with hepatocellular carcinoma: Nonalcoholic fatty liver disease versus viral hepatitis.
    Matsumoto T; Shiraki T; Tanaka G; Yamaguchi T; Park KH; Mori S; Iso Y; Ishizuka M; Kubota K; Aoki T
    World J Surg; 2024 May; 48(5):1219-1230. PubMed ID: 38468392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes after laparoscopic or open liver resection for nonalcoholic fatty liver disease-associated hepatocellular carcinoma: a propensity score-matching study.
    Watanabe Y; Aikawa M; Oshima Y; Kato T; Takase K; Watanabe Y; Okada K; Okamoto K; Koyama I
    Surg Endosc; 2024 Jul; 38(7):3887-3904. PubMed ID: 38831217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver Resection for Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: a Multicenter Propensity Matching Analysis with HBV-HCC.
    Yang T; Hu LY; Li ZL; Liu K; Wu H; Xing H; Lau WY; Pawlik TM; Zeng YY; Zhou YH; Gu WM; Wang H; Chen TH; Han J; Li C; Wang MD; Wu MC; Shen F
    J Gastrointest Surg; 2020 Feb; 24(2):320-329. PubMed ID: 30617773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients undergoing liver resection for non-alcoholic fatty liver disease-related hepatocellular carcinoma and those for viral hepatitis-related hepatocellular carcinoma have similar survival outcomes.
    Yen YH; Kuo FY; Eng HL; Liu YW; Yong CC; Wang CC; Li WF; Lin CY
    Updates Surg; 2024 Jun; 76(3):879-887. PubMed ID: 38582796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of concurrent nonalcoholic fatty liver disease in patients with chronic hepatitis B-related hepatocellular carcinoma.
    Yoon JS; Lee HY; Chung SW; Kim SW; Chang Y; Lee YB; Cho EJ; Lee JH; Yu SJ; Kim H; Yoon JH; Kim YJ
    J Gastroenterol Hepatol; 2020 Nov; 35(11):1960-1968. PubMed ID: 32128882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes Mellitus and/or Nonalcoholic Steatohepatitis-related Hepatocellular Carcinoma Showed Favorable Surgical Outcomes After Hepatectomy.
    Liang J; Ariizumi SI; Nakano M; Yamamoto M
    Anticancer Res; 2019 Oct; 39(10):5639-5643. PubMed ID: 31570461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal trends, clinical patterns and outcomes of NAFLD-related HCC in patients undergoing liver resection over a 20-year period.
    Pais R; Fartoux L; Goumard C; Scatton O; Wendum D; Rosmorduc O; Ratziu V
    Aliment Pharmacol Ther; 2017 Nov; 46(9):856-863. PubMed ID: 28857208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term surgical outcomes of Non alcoholic fatty liver disease associated hepatocellular carcinoma.
    D'Silva M; Cho JY; Han HS; Yoon YS; Lee HW; Lee JS; Lee B; Kim M
    Surg Oncol; 2022 May; 41():101730. PubMed ID: 35231745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Hepatic Steatosis on Disease-Free Survival in Patients with Non-B Non-C Hepatocellular Carcinoma Undergoing Hepatic Resection.
    Nishio T; Hatano E; Sakurai T; Taura K; Okuno M; Kasai Y; Seo S; Yasuchika K; Mori A; Kaido T; Uemoto S
    Ann Surg Oncol; 2015 Jul; 22(7):2226-34. PubMed ID: 25395147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis.
    Mohamad B; Shah V; Onyshchenko M; Elshamy M; Aucejo F; Lopez R; Hanouneh IA; Alhaddad R; Alkhouri N
    Hepatol Int; 2016 Jul; 10(4):632-9. PubMed ID: 26558795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended hepatic resection for hepatocellular carcinoma in patients with cirrhosis: is it justified?
    Poon RT; Fan ST; Lo CM; Liu CL; Lam CM; Yuen WK; Yeung C; Wong J
    Ann Surg; 2002 Nov; 236(5):602-11. PubMed ID: 12409666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Patterns and Outcome of Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease.
    Ahn SY; Kim SB; Song IH
    Can J Gastroenterol Hepatol; 2020; 2020():4873875. PubMed ID: 32566546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and outcome of hepatocellular carcinoma in patients with NAFLD without cirrhosis.
    Bengtsson B; Stål P; Wahlin S; Björkström NK; Hagström H
    Liver Int; 2019 Jun; 39(6):1098-1108. PubMed ID: 30829446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease.
    Wong CR; Nguyen MH; Lim JK
    World J Gastroenterol; 2016 Oct; 22(37):8294-8303. PubMed ID: 27729736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver resection for hepatocellular carcinoma in patients with metabolic syndrome: A multicenter matched analysis with HCV-related HCC.
    Viganò L; Conci S; Cescon M; Fava C; Capelli P; D'Errico A; Torzilli G; Di Tommaso L; Giuliante F; Vecchio FM; Salizzoni M; David E; Pinna AD; Guglielmi A; Capussotti L
    J Hepatol; 2015 Jul; 63(1):93-101. PubMed ID: 25646890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical outcomes for hepatocellular carcinoma in nonalcoholic fatty liver disease.
    Wakai T; Shirai Y; Sakata J; Korita PV; Ajioka Y; Hatakeyama K
    J Gastrointest Surg; 2011 Aug; 15(8):1450-8. PubMed ID: 21512848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features of hepatocellular carcinoma in nonalcoholic fatty liver disease patients without advanced fibrosis.
    Kodama K; Kawaguchi T; Hyogo H; Nakajima T; Ono M; Seike M; Takahashi H; Nozaki Y; Kawanaka M; Tanaka S; Imajo K; Sumida Y; Kamada Y; Fujii H; Seko Y; Takehara T; Itoh Y; Nakajima A; Masaki N; Torimura T; Saibara T; Karino Y; Chayama K; Tokushige K
    J Gastroenterol Hepatol; 2019 Sep; 34(9):1626-1632. PubMed ID: 30668889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in hepatocellular carcinoma due to non-alcoholic fatty liver disease.
    Bertot LC; Adams LA
    Expert Rev Gastroenterol Hepatol; 2019 Feb; 13(2):179-187. PubMed ID: 30791782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival after treatment with curative intent for hepatocellular carcinoma among patients with vs without non-alcoholic fatty liver disease.
    Wong CR; Njei B; Nguyen MH; Nguyen A; Lim JK
    Aliment Pharmacol Ther; 2017 Dec; 46(11-12):1061-1069. PubMed ID: 28960360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.